|Articles|June 1, 2001

New Opportunities to Optimize Antimicrobial Treatment
Volume 7
Issue 6 Suppl

Challenges of Managed Care Organizations in Treating Respiratory Tract Infections in an Age of Antibiotic Resistance

Download PDF: Challenges of Managed Care Organizations in Treating Respiratory Tract Infections in an Age of Antibiotic Resistance

Articles in this issue

about 25 years ago

Article

Introduction

about 25 years ago

Article

The Crisis of Resistant Pathogens in Respiratory Tract Infections -- Use of Pharmacodynamic Principles

about 25 years ago

Article

Appropriate Antibiotic Use in Treating Respiratory Tract Infections

about 25 years ago

Article

Clinical Practice Guidelines for the Diagnosis and Treatment of Respiratory Tract Infections

about 25 years ago

Article

Continuing Medical Education Quiz

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

State Medicaid Budgetary Implications of New Cancers

ByAmanda C. Chen, PhD,Anuraag R. Kansal, PhD,David C. Grabowski, PhD

July 2nd 2026

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

ByKaitlyn T. Haas, PharmD,Joseph J. Saseen, PharmD, BCPS, BCACP,Oliver Titus, MS,Nathan Lamberton, PharmD, BCACP,Lisa M. Schilling, MD, MSPH,Keri N. Hogan, PharmD, BCACP,Alison Marks, BA,Sarah J. Billups, PharmD, BCPS

July 1st 2026

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Challenges of Managed Care Organizations in Treating Respiratory Tract Infections in an Age of Antibiotic Resistance

Articles in this issue

Related Content

State Medicaid Budgetary Implications of New Cancers

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Trending on AJMC

COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV

Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure

3 Considerations for Oncology Pharmacy Care Delivery: Minhee Kang, PharmD

Kazia Therapeutics Discusses Shift for Paxalisib Into Triple-Negative Breast Cancer

SYNC-T: Immunotherapy Platform Brings 4-Part Attack in Prostate Cancer, With More Trials Planned

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Challenges of Managed Care Organizations in Treating Respiratory Tract Infections in an Age of Antibiotic Resistance

Articles in this issue

Related Content

State Medicaid Budgetary Implications of New Cancers

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Trending on AJMC

COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV

Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure

3 Considerations for Oncology Pharmacy Care Delivery: Minhee Kang, PharmD

Kazia Therapeutics Discusses Shift for Paxalisib Into Triple-Negative Breast Cancer

SYNC-T: Immunotherapy Platform Brings 4-Part Attack in Prostate Cancer, With More Trials Planned